Original article
Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer

https://doi.org/10.1016/S0748-7983(97)92885-7Get rights and content

Sentinel node (SN) biopsy technique has been reported to be a very accurate staging procedure in patients with stage I/II melanoma. Whether it is as accurate in patients with breast cancer has to be studied more extensively. Eighty-three patients with clinically T1—T2 N0M0 breast cancer were peri-tumorally injected with 99m-Tc colloidal-albumin. Lymphoscintigraphy was performed either 4 or 18 h after the injection. Using a gamma probe the SN were located in vivo, removed from the axillary specimen and sent for histological examination. No focal accumulation was seen on the lymphoscintigraphy in 17 patients. Two patients had parasternal SN locations only and in seven patients the localization of the SN failed. Of the remaining 57 patients, 23 had positive axillary basins, of which 22 were correctly predicted by one or more positive SN. There was one false-negative biopsy (sensitivity = 96%). In 12 of the 22 positive axillary basins, SN was the only positive node. We conclude that the SN biopsy technique is a promising and feasible procedure in about three-quarters of patients with clinically T1—T2 N0M0 breast cancer. However, more data are needed to establish the actual sensitivity of this procedure.

References (30)

  • FentimanIS et al.

    Current controversies in cancer: is routine axillary nodal dissection necessary in the treatment of breast cancer?

    Eur J Cancer

    (1996)
  • CabanasRM

    An approach for the treatment of penile carcinoma

    Cancer

    (1977)
  • MortonDL et al.

    Technical details of intraoperative lymphatic mapping for early stage melanoma

    Arch Surg

    (1992)
  • PijpersR et al.

    Impact of lymphoscintigraphy on sentinel node identification with Technetium-99m-colloidal albumin in breast cancer

    J Nucl Med

    (1997)
  • ColletGJ et al.

    Sentinel node procedure in breast cancer using Tc 99m-colloidal albumin

    Eur J Surg Oncol

    (1996)
  • Cited by (0)

    View full text